A number of experimental papers that we will critically analyze hereinafter have focused on the antineoplastic effects of LCn-3 PUFA in breast cancer cell lines or in animals, and associated them with their ability to alter the expression/activity of ERK1/2 and/or Akt. This evidence concerns the gene AKT1 and breast carcinoma.